Ligand Pharmaceuticals LGND Available-for-Sale Debt Securities - Fair Value (Maturing Within 1 Year)

Available-for-Sale Debt Securities - Fair Value (Maturing Within 1 Year) at other companies

Banner CorporationBANR

$7.41M+112%

Bank of HawaiiBOH

$105.97M—

PopularBPOP

$2.56B+325%

Cal-Maine FoodsCALM

$353.52M-16.6%

Corebridge FinancialCRBG

$3.31B-1.1%

GBC

Glacier BancorpGBCI

$308.08M-41.3%

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.6B+96.7%

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's available-for-sale debt securities - fair value (maturing within 1 year).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's available-for-sale debt securities - fair value (maturing within 1 year)?: Ligand Pharmaceuticals (LGND) reported available-for-sale debt securities - fair value (maturing within 1 year) of $351.07M in Q1 2026.
How has Ligand Pharmaceuticals's available-for-sale debt securities - fair value (maturing within 1 year) changed year-over-year?: Ligand Pharmaceuticals's available-for-sale debt securities - fair value (maturing within 1 year) increased by 181.0% year-over-year, from $124.95M to $351.07M.